References
- Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al.. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 2001;344:732–8
- Himi T, Takano K, Yamamoto M, Naishiro Y, Takahashi H. A novel concept of Mikulicz's disease as IgG4-related disease. Auris Nasus Larynx 2012;39:9–17
- Takano K, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Himi T. Clinicopathologic similarities between Mikulicz disease and Küttner tumor. Am J Otolaryngol Head Neck Surg 2010;31:429–34.
- Ohta N, Makihara S, Okano M, Kurakami K, Ishida A, Furukawa T et al.. Roles of IL-17, Th1, and Tc1 cells in patients with IgG4-related sclerosing sialadenitis. Laryngoscope 2012;122:2169–74
- Ohta N, Kurakami K, Ishida A, Furukawa T, Saito F, Kakehata S et al.. Clinical and pathological characteristics of IgG4-related sclerosing sialadenitis. Laryngoscope 2012;122:572–7
- Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A et al.. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res. Ther. 2012;14:R171
- Nishizawa H, Matsubara A, Nakagawa T, Ohta N, Izuhara K, Shirasaki T et al.. The role of periostin in eosinophilic otitis media. Acta Otolaryngol. 2012;132:838–44
- Ishida A, Ohta N, Suzuki Y, Kakehata S, Okubo K, Ikeda H et al.. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 2012;61:589–95
- Ohta N, Watanabe T, Ito T, Kubota T, Suzuki Y, Ishida A et al.. Clinical and pathological characteristics of organized hematoma. Int J Otolaryngol 2013;2013;539–642
- Makihara S, Okano M, Fujiwara T, Kariya S, Noda Y, Higaki T et al.. Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation. J. Allergy Clin. Immunol. 2010;:397–400
- Fragoulis GE, Moutsopoulos HM. IgG4 syndrome: old disease, new perspective. J. Rheumatol. 2010;37:1369–70
- Conway SJ, Doetschman T, Azhar M. The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. Sci World J 2011;11:1509–24.
- Wen W, Chau E, Jackson-Boeters L, Elliott C, Daley TD, Hamilton DW. TGF-ß1 and FAK regulate periostin expression in PDL fibroblasts. J. Dent. Res. 2010;89:1439–43
- Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L et al.. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc. Natl. Acad. Sci. U.S.A. 2010;107:14170–5
- Li L, Wang C, Wang JY, Cui XB, Wu D, Zhou Y, et al.. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibrosis. Cardiovasc Res 2011;91:80–9.
- Tininger K, Treis A, Fucik P, Gona M, Gruber S, Renner S, et al.A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2013;187:621–9.
- Nishimura Y, Inoue T, Nitto T, Morooka T, Node K. Increased interleukin-13 levels in patients with chronic heart failure. Int. J. Cardiol. 2009;131:421–3
- Nanke Y, Kobashigawa T, Yago T, Kamatani N, Kotake S. A case of Mikulicz’s disease, IgG4-related plasmacytic syndrome, successfully treated by corticosteroid and mizoribine, followed by mizoribine alone. Internal Med 2010;49:1449–53.
- Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum2010;62:1755–62
- Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010;10:217–19